Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Trichodynia is a painful scalp condition linked to hair loss and inflammation, often with anxiety, affecting more women and needing better treatment options.

Runx1 controls fat-related genes important for normal and cancer cell growth, affecting skin and hair cell behavior.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Hes1 protein is important for hair growth and regeneration, and could be a potential treatment for hair loss.

Hair follicle stem cells are promising for wound healing but require more research for safe clinical use.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

The study found stem cells in minor salivary glands that can differentiate and are involved in tumor formation when exposed to tobacco.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

Bioactive molecules show promise for improving skin repair and regeneration by overcoming current challenges with further research.

The formula YH0618 can reduce the harmful side effects of the chemotherapy drug Doxorubicin and protect healthy cells.

Inhibiting AP1 in mice skin causes structural changes and weakens the skin barrier.

The conclusion is that a thorough approach is needed to diagnose and manage hyperandrogenism in teenage girls, recognizing its major psychological and health effects.

The study found new details about human hair growth and suggests that preventing a specific biological pathway could potentially treat hair graying.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

Estrogens are key for bone growth spurts in both boys and girls and affect growth into adulthood.

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.

Low ERCC3 gene activity is linked to non-pigmented hair growth.

Diagnosing PCOS in teenage girls is tricky and requires careful evaluation and management.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

Human hair varies widely and should be classified by curl type rather than race.

Hyperadrenocorticism in ferrets is linked to neutering and indoor housing, and is best treated with surgery and a deslorelin implant.

Women with epilepsy on certain medications might gain weight and have higher thyroid-stimulating hormone levels, but not more polycystic ovarian syndrome.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Etifoxine, an anxiety drug, can lessen brain inflammation and cognitive issues in mice, partly by increasing production of protective brain steroids.

Finding new uses for existing drugs is promising and can lead to safer, more effective medicines.

Lymphatic vessels are essential for health and can be targeted to treat various diseases.